Learn about Adrenal Gland Mass diagnosis, including clinical documentation and medical coding for Adrenal Incidentaloma and Adrenal Tumor. Find information on healthcare best practices related to an Adrenal Gland Mass, covering diagnosis, treatment, and patient care. This resource offers guidance for accurate medical coding and appropriate clinical documentation of Adrenal Incidentaloma and Adrenal Tumor.
Also known as
Disorders of adrenal gland
Covers various adrenal gland conditions, including masses and tumors.
Benign neoplasm of adrenal gland
Specifically designates non-cancerous adrenal gland growths.
Malignant neoplasm of adrenal gland
Identifies cancerous tumors originating in the adrenal gland.
Abnormal findings on diagnostic imaging of other adrenal glands
Captures incidental findings like masses detected during imaging.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the adrenal gland mass functional (hormone-producing)?
When to use each related code
| Description |
|---|
| Growth in adrenal gland, often non-cancerous. |
| Overproduction of cortisol by adrenal gland. |
| Tumor of adrenal gland producing excess adrenaline. |
Missing documentation specifying right, left, or bilateral adrenal gland involvement can lead to coding errors and claim denials.
Incomplete documentation of malignancy status (benign, uncertain behavior, primary, or metastatic) impacts accurate coding and reimbursement.
If incidentaloma is documented, further evaluation and documentation are needed to exclude functional or malignant tumors for proper coding.
Q: How can I differentiate between a benign adrenal incidentaloma and a malignant adrenal tumor in a patient with an adrenal gland mass?
A: Differentiating between a benign adrenal incidentaloma and a malignant adrenal tumor requires a multi-faceted approach. Begin with a thorough patient history and physical exam, focusing on symptoms such as hypertension, weight gain, or hirsutism, which can suggest hormone-producing tumors. Biochemical evaluation is crucial, including tests for plasma metanephrines to rule out pheochromocytoma, serum aldosterone and renin activity for aldosteronoma, and a 1 mg overnight dexamethasone suppression test for Cushing's syndrome. Imaging plays a vital role; consider contrast-enhanced CT to assess size, shape, and density, and MRI for further characterization if needed. Size is a significant factor, with masses greater than 4 cm warranting closer scrutiny. Explore how specific imaging characteristics, like homogenous density and rapid washout, can suggest benignity, while irregular margins and heterogeneous enhancement raise concern for malignancy. Consider implementing a follow-up imaging protocol for smaller, stable incidentalomas to monitor for growth. Ultimately, if suspicion for malignancy is high, biopsy or surgical resection may be necessary. Learn more about the role of fine-needle aspiration biopsy in the diagnosis of adrenal masses.
Q: What is the recommended follow-up imaging protocol for an asymptomatic patient with a small, non-functioning adrenal incidentaloma discovered on abdominal CT?
A: For asymptomatic patients with a small (less than 4 cm), non-functioning adrenal incidentaloma discovered incidentally on abdominal CT, the recommended follow-up imaging protocol generally involves repeat imaging at 6-12 months to assess for growth. If the incidentaloma remains stable in size and appearance after the initial follow-up, further imaging may be performed at 2-3 year intervals. However, individual patient factors, such as age, comorbidities, and family history, should be considered when determining the optimal follow-up schedule. Hormonal evaluation should also be repeated at intervals determined by initial results and clinical suspicion. Explore how the American College of Radiology Appropriateness Criteria can provide further guidance on adrenal incidentaloma management and consider implementing a standardized follow-up protocol within your practice. Learn more about the long-term risks associated with untreated adrenal incidentalomas.
Patient presents with an adrenal gland mass, also known as an adrenal incidentaloma or adrenal tumor, discovered incidentally during imaging performed for unrelated reasons. The patient's current symptoms, if any, are documented, including but not limited to abdominal pain, flank pain, back pain, hypertension, unexplained weight loss or gain, fatigue, and changes in bowel habits. Physical examination findings are noted, including palpation of the abdomen and assessment for signs of Cushing syndrome, Conn syndrome, or pheochromocytoma. Differential diagnosis includes benign adrenal adenoma, adrenocortical carcinoma, pheochromocytoma, myelolipoma, and metastasis. Initial laboratory evaluation includes a comprehensive metabolic panel, complete blood count, hormonal evaluation including cortisol, aldosterone, renin, and metanephrines. Imaging studies reviewed and considered include CT scan of the abdomen and pelvis with contrast, MRI of the adrenal glands, and potentially adrenal venous sampling. Management options discussed with the patient include watchful waiting with serial imaging and hormonal evaluation, surgical resection, or further investigation to characterize the mass. The decision for surgical intervention is based on size, imaging characteristics, hormonal activity, and patient preference. Patient education provided regarding the potential risks and benefits of each treatment option. ICD-10 coding for the adrenal gland mass will be determined based on the specific diagnosis and characterization of the mass, such as D35.0 for benign neoplasm of adrenal gland, C74.1 for malignant neoplasm of adrenal gland, or E27.1 for hyperfunctioning adrenal gland. CPT codes for procedures performed, such as adrenalectomy or biopsy, will be documented appropriately. Follow-up imaging and hormonal evaluation scheduled to monitor the adrenal mass and assess for any changes.